TotalMarketCap

Century Therapeutics

IPSCNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$273.424 M

$1.51 -9.58%

Close of 6 Nov 2026

As of 6 Nov 2026, Century Therapeutics (IPSC) has a market capitalization of $273.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$109.2M

#2460 by revenue

Earnings

-$9.58M

Loss-making

Shares outstanding

181,075,321

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #86OcugenOCGN$276.5M
  2. #87Precision BiosciencesDTIL$274.7M
  3. #88Century TherapeuticsIPSC$273.4M
  4. #89SAB BiotherapeuticsSABS$266.6M
  5. #90Lineage Cell TherapeuticsLCTX$247.3M

What if Century Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$155,939.94

Per share 103,271× higher

Bitcoin $1.53T

$8,437.64

Per share 5,588× higher

Apple $5.02T

$27,699.98

Per share 18,344× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Century Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.